DISCOVER LCC
LCC was founded in 2014 at the University of Liverpool, with a mission of improving access to novel, chiral chemical space.
LCC are 10 years in development, supported by VC investment (>£10m) and have built a chemistry platform which can be used alongside biology and screening capabilities to develop potential drug candidates.
Key capabilities/assets:
Proprietary chemical space of >1-billion novel, diverse, chiral small molecules.
Automation lab capable of producing 1,000 test samples per month.
An experienced team supported by investors and scientific advisory board
“LCC’s billion-member chiral library is more 3-dimensional, novel and diverse than other chemical spaces, which has led to superior performance inside our quantum-computing platform and identification of higher quality small molecule ligands, increasing the likelihood of successful project outcomes.”
Dr Shahar Keinan (CEO), POLARISQB